Palatin enrols first subject in Phase II ulcerative colitis therapy trial

cafead

Administrator
Staff member
  • cafead   Oct 21, 2022 at 10:52: AM
via Palatin Technologies has announced the enrolment of the first patient in the Phase II PL8177-205 clinical trial of PL8177 for ulcerative colitis (UC), a chronic large intestine disease.

article source
 

<